Terumo

Terumo EBIT

The EBIT of Terumo (4543.T) as of Nov 2, 2026 is 184.74 B JPY. In the previous year, EBIT was 179.02 B JPY — a change of 3.19% (higher).

EBIT

184.74 BJPY

YoY

3.19%

Last updated:

In 2026, Terumo's EBIT was 184.74 B JPY, a 3.19% increase from the 179.02 B JPY EBIT recorded in the previous year.

The Terumo EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2024
134.20 B JPY
Jan 1, 2025
179.02 B JPY
Jan 1, 2026
184.74 B JPY
Jan 1, 2027 (e)
199.62 B JPY
Jan 1, 2028 (e)
244.91 B JPY
Jan 1, 2029 (e)
268.67 B JPY
Jan 1, 2030 (e)
315.66 B JPY
Jan 1, 2031 (e)
345.67 B JPY
The Terumo EBIT history
YEAREBITYoY
est345.67 BJPY+9.51%
est315.66 BJPY+17.49%
est268.67 BJPY+9.70%
est244.91 BJPY+22.69%
est199.62 BJPY+8.05%
184.74 BJPY+3.19%
179.02 BJPY+33.40%
134.20 BJPY+14.37%
117.33 BJPY-0.67%
118.12 BJPY+20.91%
97.69 BJPY-10.20%
108.79 BJPY+4.22%
104.39 BJPY-2.42%
106.97 BJPY+18.14%
90.55 BJPY+10.82%
81.70 BJPY+21.12%
67.46 BJPY+3.32%
65.29 BJPY+22.68%
53.22 BJPY-15.60%
63.05 BJPY+0.71%
62.61 BJPY-1.07%
63.28 BJPY+17.10%
54.04 BJPY-19.27%
66.94 BJPY+14.52%
58.46 BJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Terumo Revenue

Terumo Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2024
921.86 B JPY
134.20 B JPY
106.37 B JPY
Jan 1, 2025
1.04 T JPY
179.02 B JPY
116.98 B JPY
Jan 1, 2026
1.13 T JPY
184.74 B JPY
135.91 B JPY
Jan 1, 2027 (e)
1.25 T JPY
199.62 B JPY
150.37 B JPY
Jan 1, 2028 (e)
1.32 T JPY
244.91 B JPY
191.48 B JPY
Jan 1, 2029 (e)
1.41 T JPY
268.67 B JPY
210.81 B JPY
Jan 1, 2030 (e)
1.50 T JPY
315.66 B JPY
240.08 B JPY
Jan 1, 2031 (e)
1.60 T JPY
345.67 B JPY
263.09 B JPY

Terumo Margins

Terumo stock margins

The Terumo margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Terumo. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Terumo.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2024
49.27 %
14.56 %
11.54 %
Jan 1, 2025
51.42 %
17.28 %
11.29 %
Jan 1, 2026
52.54 %
16.32 %
12.01 %
Jan 1, 2027 (e)
52.54 %
15.91 %
11.98 %
Jan 1, 2028 (e)
52.54 %
18.49 %
14.46 %
Jan 1, 2029 (e)
52.54 %
19.08 %
14.97 %
Jan 1, 2030 (e)
52.54 %
21.05 %
16.01 %
Jan 1, 2031 (e)
52.54 %
21.57 %
16.42 %

Terumo Stock analysis

What does Terumo do? Terumo Corporation is a Japanese company that was founded in 1921. The company is headquartered in Tokyo and specializes in the development, manufacturing, and marketing of medical products and devices. It has a global presence and employs approximately 28,000 people in over 160 countries. The company's history began with the establishment of a small medical device company called Sekisen Kenonsha, founded by a group of doctors. In 1942, the company merged with another company named Terumo Sougou Kenkyuusho and became Terumo Corporation. Since then, the company has continuously expanded and diversified its product range. Terumo's business model focuses on providing solutions to improve people's health worldwide through the development of innovative medical devices and products. The company operates in three main business areas: 1. Interventional Systems: This business area specializes in the development of catheters, stent systems, and other medical products for cardiac, peripheral, and vascular interventions. 2. Blood Systems: This business area offers a wide range of products for blood collection and processing, including disposable syringes for blood collection and venous and arterial access systems. 3. Biosciences: This business area focuses on the development of products for cell culture and regenerative medicine, including stem cell therapy and cell banks for research. Terumo distributes its products not only directly to hospitals and medical facilities but also collaborates closely with distributors and partners to reach a wider customer base. Additionally, the company invests significant resources in research and development to continuously expand its product range. Among the products that Terumo offers, some of the most advanced and innovative medical devices on the market can be found. One example is the state-of-the-art catheters and stent systems that enable doctors to perform minimally invasive procedures to treat serious cardiovascular diseases. Terumo also produces disposable syringes that are widely used due to their high quality and reliability. In recent years, Terumo has also invested in regenerative medicine by developing products for cell culture and therapy. This includes stem cell therapy products that can be used in the treatment of certain cancers and blood disorders. Overall, Terumo Corporation has a long history as one of the leading companies in the medical technology industry. With its innovative products and strong focus on research and development, the company will continue to play an important role in improving the health and well-being of people worldwide. Terumo is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Terumo's EBIT

Terumo's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Terumo's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Terumo's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Terumo’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Terumo stock

EBIT of Terumo is 184.74 B JPY in 2026.

EBIT of Terumo changed from 179.02 B JPY to 184.74 B JPY, representing a 3.19% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Terumo since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Terumo historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Terumo

All Key Metrics — Terumo